AtriCure has been granted a patent for a device and method for forming a lesion on the endocardial tissue of a patient’s heart. The device includes an ablation assembly and a guiding assembly, both of which have attraction elements that can be attracted via magnetism. The device allows for the formation of an ablation on the cardiac tissue by moving the guiding assembly, which in turn moves the ablation element of the ablation assembly. GlobalData’s report on AtriCure gives a 360-degree view of the company including its patenting strategy. Buy the report here.
Smarter leaders trust GlobalData
According to GlobalData’s company profile on AtriCure, surgical robots was a key innovation area identified from patents. AtriCure's grant share as of September 2023 was 55%. Grant share is based on the ratio of number of grants to total number of patents.
A device for forming lesions on endocardial tissue
A recently granted patent (Publication Number: US11759254B2) describes a device for forming a lesion on the endocardial tissue of a patient's heart. The device consists of two elongated catheters and an ablation assembly.
The first elongated catheter includes an ablation element, an expanding element, a first attraction element, and an inflation lumen. The expanding element, which is in fluid communication with the inflation lumen, extends circumferentially around part of the first elongated catheter. When the first elongated catheter is placed within the heart, the expanding element expands to create a space between the ablation element and the endocardial tissue. This space isolates the ablation element from the blood flowing in the patient's heart. The first elongated catheter also includes a temperature sensing element.
The second elongated catheter comprises a second attraction element that is magnetically attracted to the first attraction element. The magnetic attraction between these two elements allows for the rotational orientation of the ablation element relative to the endocardial tissue.
The ablation assembly, which is part of the device's guiding assembly, includes an ablation element, an expanding element, and a first attraction element. The expanding element extends circumferentially around the ablation assembly at two different locations, with the ablation element positioned between these locations. Similar to the first elongated catheter, the expanding element isolates the ablation element from the blood flowing in the patient's heart. The ablation assembly also includes a temperature sensing element.
Overall, this patented device offers a novel approach to forming lesions on the endocardial tissue of a patient's heart. By utilizing expanding elements and magnetic attraction, the device provides improved isolation of the ablation element and allows for precise rotational orientation. These features may contribute to more effective and targeted treatment of heart conditions.
To know more about GlobalData’s detailed insights on AtriCure, buy the report here.
Data Insights
From
The gold standard of business intelligence.
Blending expert knowledge with cutting-edge technology, GlobalData’s unrivalled proprietary data will enable you to decode what’s happening in your market. You can make better informed decisions and gain a future-proof advantage over your competitors.
GlobalData, the leading provider of industry intelligence, provided the underlying data, research, and analysis used to produce this article.
GlobalData Patent Analytics tracks bibliographic data, legal events data, point in time patent ownerships, and backward and forward citations from global patenting offices. Textual analysis and official patent classifications are used to group patents into key thematic areas and link them to specific companies across the world’s largest industries.
